Inventiva Pharma

Beleggen in aandelen beurzen Frankfurt DAX, Londen FTSE 100, Parijs CAC40
beursfre
Forum gebruiker
Forum gebruiker
Berichten: 131
Lid geworden op: 02 mar 2018 15:26
waarderingen: 28
Contacteer:

Re: Inventiva Pharma

Bericht door beursfre »

cijfers bij bio en/of pharma is altijd afwachten
want vaak draait het niet enkel daarom
Asit (0,23) - Biocartis (4,10) - IBA (9,15) - Inventiva (2,75) - Mdx (0,90) - PostNl (1,40)- Pharming (1,17) - Orange (18,00) - Wereldhave (11,50) - Shell (15,10) - Oxurion (2,70)



NewB76
Forum actieveling
Forum actieveling
Berichten: 708
Lid geworden op: 21 jul 2018 13:41
waarderingen: 154
Contacteer:

Re: Inventiva Pharma

Bericht door NewB76 »

Genoeg geld voor een jaar activiteit, hopelijk goed ontvangst op de talrijke conferenties en dan wachten op het NASH-resultaat.

Gebruikersavatar
And its gone!
Forum actieveling
Forum actieveling
Berichten: 631
Lid geworden op: 30 mei 2018 21:25
waarderingen: 242
Contacteer:

Re: Inventiva Pharma

Bericht door And its gone! »

BRIEF-Inventiva Completes Capital Increase Of 15 Million Euros
08:13 (07/02) - Bron: Reuters
Feb 7 (Reuters) - Inventiva SA IVAA.PA :
* INVENTIVA COMPLETES A CAPITAL INCREASE OF €15 M SUBSCRIBED
BY
EXISTING SHAREHOLDERS
* NEW FINANCING WILL ENABLE COMPANY TO EXTEND ITS CASH
RUNWAY TO
END OF Q2 2021
* CAPITAL INCREASE SUBSCRIBED BY BVF PARTNERS L.P., NEW
ENTERPRISE
ASSOCIATES (NEA), NOVO HOLDINGS A/S, AND SOFINNOVA PARTNERS
* CAPITAL RAISED AT CLOSING PRICE OF FEBRUARY 6, 2020
WITHOUT
DISCOUNT

* CAPITAL INCREASE SUBSCRIBED BY BVF PARTNERS L.P., NEW
ENTERPRISE
ASSOCIATES (NEA), NOVO HOLDINGS A/S, AND SOFINNOVA PARTNERS
* INVENTIVA SA CONSIDERS THAT THIS CAPITAL INCREASE WILL
ENABLE
COMPANY TO EXTEND ITS CASH RUNWAY FROM MIDDLE OF Q1 OF 2021 TO
END OF Q2 OF 2021
.
* ISSUANCE OF 3,778,338 NEW SHARES WITH A NOMINAL VALUE OF
EUR
0.01 EACH FOR SUBSCRIPTION PRICE OF EUR 3.97 EACH (INCLUDING
PREMIUM)
* FOLLOWING SETTLEMENT AND DELIVERY EXPECTED TO OCCUR ON
FEBRUARY
11, 2020, INVENTIVA'S SHARE CAPITAL WILL AMOUNT TO EUR
306,877.50 DIVIDED INTO 30 687 750 SHARES
* NEW SHARES WILL BE FUNGIBLE WITH EXISTING SHARES OF
COMPANY AND
WILL BE ADMITTED TO TRADING ON REGULATED MARKET OF EURONEXT
PARIS

Source text for Eikon:
Further company coverage:

(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Dat was snel! :clap:
Terugnajaren liked last!
GOOGL, BAYN, DBK, CYAD, TNG, ALPHA, IPH, RDSA, IVA, VYGR, HARP, YMAB, BCYC, ZYME, GERN, BNTX, SWTX, BPMC, RCUS, TRIL.

Terugnajaren
Forum gebruiker
Forum gebruiker
Berichten: 174
Lid geworden op: 19 jul 2019 13:50
waarderingen: 199
Contacteer:

Re: Inventiva Pharma

Bericht door Terugnajaren »

And its gone! schreef:
07 feb 2020 08:22
BRIEF-Inventiva Completes Capital Increase Of 15 Million Euros
08:13 (07/02) - Bron: Reuters
Feb 7 (Reuters) - Inventiva SA IVAA.PA :
* INVENTIVA COMPLETES A CAPITAL INCREASE OF €15 M SUBSCRIBED
BY
EXISTING SHAREHOLDERS
* NEW FINANCING WILL ENABLE COMPANY TO EXTEND ITS CASH
RUNWAY TO
END OF Q2 2021
* CAPITAL INCREASE SUBSCRIBED BY BVF PARTNERS L.P., NEW
ENTERPRISE
ASSOCIATES (NEA), NOVO HOLDINGS A/S, AND SOFINNOVA PARTNERS
* CAPITAL RAISED AT CLOSING PRICE OF FEBRUARY 6, 2020
WITHOUT
DISCOUNT

* CAPITAL INCREASE SUBSCRIBED BY BVF PARTNERS L.P., NEW
ENTERPRISE
ASSOCIATES (NEA), NOVO HOLDINGS A/S, AND SOFINNOVA PARTNERS
* INVENTIVA SA CONSIDERS THAT THIS CAPITAL INCREASE WILL
ENABLE
COMPANY TO EXTEND ITS CASH RUNWAY FROM MIDDLE OF Q1 OF 2021 TO
END OF Q2 OF 2021
.
* ISSUANCE OF 3,778,338 NEW SHARES WITH A NOMINAL VALUE OF
EUR
0.01 EACH FOR SUBSCRIPTION PRICE OF EUR 3.97 EACH (INCLUDING
PREMIUM)
* FOLLOWING SETTLEMENT AND DELIVERY EXPECTED TO OCCUR ON
FEBRUARY
11, 2020, INVENTIVA'S SHARE CAPITAL WILL AMOUNT TO EUR
306,877.50 DIVIDED INTO 30 687 750 SHARES
* NEW SHARES WILL BE FUNGIBLE WITH EXISTING SHARES OF
COMPANY AND
WILL BE ADMITTED TO TRADING ON REGULATED MARKET OF EURONEXT
PARIS

Source text for Eikon:
Further company coverage:

(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Dat was snel! :clap:
Zelfs geen PB ontvangen in mailbox hierover, vreemd.

Terugnajaren
Forum gebruiker
Forum gebruiker
Berichten: 174
Lid geworden op: 19 jul 2019 13:50
waarderingen: 199
Contacteer:

Re: Inventiva Pharma

Bericht door Terugnajaren »

PB

Inventiva to present at the Cowen and Company 40th Annual Health Care Conference

Daix (France), February 19, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas of fibrosis, lysosomal storage disorders and oncology, today announced that that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, will present a corporate overview, followed by a breakout session, at the upcoming Cowen and Company 40th Annual Health Care Conference, being held on March 2-4, 2020, at the Boston Marriott Copley Place hotel in Boston, USA.

The presentation details are as follows:
Date: Monday, March 2, 2020
Time of presentation: 4:10 pm – 4:40 pm (Eastern time)
Breakout session: 4:50 pm – 5:20 pm (Eastern time)
Location: Boston Marriott Copley Place hotel, 110 Huntington Avenue, Boston, USA
Webcast: http://wsw.com/webcast/cowen57/iva/

The presentation document and the link to the webcast will also be available on Inventiva’s website in the “Investors” – “Investor Presentations” section.

(ingekort)

Grtz,
Terugnajaren
And its gone! liked last!

beursfre
Forum gebruiker
Forum gebruiker
Berichten: 131
Lid geworden op: 02 mar 2018 15:26
waarderingen: 28
Contacteer:

Re: Inventiva Pharma

Bericht door beursfre »

iemand enig idee van deze val?
Asit (0,23) - Biocartis (4,10) - IBA (9,15) - Inventiva (2,75) - Mdx (0,90) - PostNl (1,40)- Pharming (1,17) - Orange (18,00) - Wereldhave (11,50) - Shell (15,10) - Oxurion (2,70)

Gebruikersavatar
And its gone!
Forum actieveling
Forum actieveling
Berichten: 631
Lid geworden op: 30 mei 2018 21:25
waarderingen: 242
Contacteer:

Re: Inventiva Pharma

Bericht door And its gone! »

beursfre schreef:
24 feb 2020 09:21
iemand enig idee van deze val?
:lol:

https://www.tijd.be/markten-live/overzicht.html

Corona paniek. Gewoon kalm blijven.
GOOGL, BAYN, DBK, CYAD, TNG, ALPHA, IPH, RDSA, IVA, VYGR, HARP, YMAB, BCYC, ZYME, GERN, BNTX, SWTX, BPMC, RCUS, TRIL.

beursfre
Forum gebruiker
Forum gebruiker
Berichten: 131
Lid geworden op: 02 mar 2018 15:26
waarderingen: 28
Contacteer:

Re: Inventiva Pharma

Bericht door beursfre »

And its gone! schreef:
24 feb 2020 09:33
beursfre schreef:
24 feb 2020 09:21
iemand enig idee van deze val?
:lol:

https://www.tijd.be/markten-live/overzicht.html

Corona paniek. Gewoon kalm blijven.
had al zo een vermoeden dat het kudde mentaliteit was :)
Asit (0,23) - Biocartis (4,10) - IBA (9,15) - Inventiva (2,75) - Mdx (0,90) - PostNl (1,40)- Pharming (1,17) - Orange (18,00) - Wereldhave (11,50) - Shell (15,10) - Oxurion (2,70)

Gebruikersavatar
And its gone!
Forum actieveling
Forum actieveling
Berichten: 631
Lid geworden op: 30 mei 2018 21:25
waarderingen: 242
Contacteer:

Re: Inventiva Pharma

Bericht door And its gone! »

BRIEF-Inventiva FY Net Loss Narrows To 30.2 Million Euros
18:13 (10/03) - Bron: Reuters
March 10 (Reuters) - INVENTIVA SA IVAA.PA :
* 2019 FULL-YEAR RESULTS: SIGNIFICANT PROGRESS IN NASH, MPS
VI AND
PSORIASIS, AND EXTENDED CASH RUNWAY
* AS AT DECEMBER 31, 2019, COMPANY'S CASH AND CASH
EQUIVALENTS
AMOUNTED TO EUR 35.8 MILLION, COMPARED TO EUR 35.3 MILLION AT
SEPTEMBER 30, 2019 AND EUR 56.7 MILLION AT DECEMBER 31, 2018
* IN 2019, INVENTIVA'S REVENUES MORE THAN DOUBLED, REACHING
EUR
7.0 MILLION, COMPARED TO EUR 3.2 MILLION IN 2018

* OTHER RECURRING OPERATING REVENUES AMOUNTED TO EUR 4.3
MILLION
IN 2019, VERSUS EUR 4.9 MILLION IN 2018, DOWN 11.5%
* INVENTIVA'S NET LOSS CAME TO - EUR 30.2 MILLION IN 2019,
COMPARED WITH A LOSS OF - EUR 33.6 MILLION IN 2018
* LANIFIBRANOR: CONFIRMATION OF PUBLICATION OF RESULTS OF
PHASE
IIB NATIVE CLINICAL STUDY EVALUATING LANIFIBRANOR IN NASH IN H1

2020 FOLLOWING COMPLETION OF PATIENT RECRUITMENT
* ABBV-157: ENROLLMENT OF FIRST PSORIASIS PATIENT IN
CLINICAL
STUDY LED BY ABBVIE AND RECEIPT OF A EUR 3.5 M MILESTONE PAYMENT
EARLIER THAN EXPECTED
* EXTENSION OF CASH RUNWAY UNTIL END OF Q2 2021
* ODIPARCIL: PUBLICATION OF POSITIVE RESULTS OF PHASE IIA
IMPROVES
CLINICAL STUDY EVALUATING ODIPARCIL IN MPS VI

Source text for Eikon:
Further company coverage:

(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
beursfre liked last!
GOOGL, BAYN, DBK, CYAD, TNG, ALPHA, IPH, RDSA, IVA, VYGR, HARP, YMAB, BCYC, ZYME, GERN, BNTX, SWTX, BPMC, RCUS, TRIL.

Gebruikersavatar
And its gone!
Forum actieveling
Forum actieveling
Berichten: 631
Lid geworden op: 30 mei 2018 21:25
waarderingen: 242
Contacteer:

Re: Inventiva Pharma

Bericht door And its gone! »

* Inventiva SA IVAA.PA : Jefferies raises price target to EUR 7 from EUR 6.50
beursfre liked last!
GOOGL, BAYN, DBK, CYAD, TNG, ALPHA, IPH, RDSA, IVA, VYGR, HARP, YMAB, BCYC, ZYME, GERN, BNTX, SWTX, BPMC, RCUS, TRIL.

Deelnemen aan het forum + meer functies?

Discussieer met duizenden beleggers, minder
advertenties, ideaal voor smartphone, betere
gebruikservaring en gratis abonneren op favoriete
onderwerpen.


Plaats reactie